微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Fulcrum Therapeutics (NASDAQ:FULC) +125%
Exagen (NASDAQ:XGN) +24%
Myomo (NYSE:MYO) +16%
IMV (NASDAQ:IMV) +8%
Allied Healthcare Products (NASDAQ:AHPI) +6%
Losers:...查看全文
$Exagen(XGN)$ 内部交易: 2021-01-21,10% Owner,Hunt Holdings Limited Partners ,卖出,50000普通股, $16.01
$Exagen(XGN)$ 内部交易: 2021-01-20,10% Owner,Hunt Holdings Limited Partners ,卖出,30000普通股, $16.13
$Exagen(XGN)$ 内部交易: 2021-01-19,10% Owner,Hunt Holdings Limited Partners ,卖出,30000普通股, $16.00
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950142-21-000211 Size: 13 KB 网页链接
$Exagen(XGN)$ 内部交易: 2021-01-19,Director,TULLIS JAMES L L ,卖出,257普通股, $15.56
$Exagen(XGN)$ 内部交易: 2021-01-15,Director,TULLIS JAMES L L ,卖出,1014普通股, $15.51
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-004370 Size: 9 KB 网页链接
$Exagen(XGN)$ 内部交易: 2021-01-13,Director,TULLIS JAMES L L ,卖出,5729普通股, $15.63
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-003854 Size: 9 KB 网页链接
$Exagen(XGN)$ 内部交易: 2021-01-12,10% Owner,Hunt Holdings Limited Partners ,卖出,15000普通股, $16.04